01:55 PM EDT, 05/21/2026 (MT Newswires) -- Healthcare stocks rose Thursday afternoon, with the NYSE Healthcare Index increasing 0.3% and the State Street Health Care Select Sector SPDR ETF (XLV) adding 0.5%.

The iShares Biotechnology ETF (IBB) was up 0.6%.

In corporate news, Eli Lilly ( LLY ) shares rose 2.1% after the company said its investigational retatrutide delivered "clinically meaningful" weight loss in a phase 3 trial, where all doses met the primary and key secondary endpoints at 80 weeks.

Hims & Hers Health ( HIMS ) said Thursday that it has launched generic semaglutide for eligible customers in Canada. Its shares popped 3.3%.

Moderna's ( MRNA ) experimental flu shot made with mRNA technology will be reviewed by a Food and Drug Administration advisory panel on June 18, Bloomberg reported. Moderna ( MRNA ) shares were down 1.5%.